Azathioprine and Aspirin in Childhood Primary Arterial Stroke
DOI:
https://doi.org/10.12974/2309-6179.2013.01.01.2Keywords:
Primary angiitis, Intracerebral hemorrhage, Multiple aneurysms, Subarachnoid hemorrhage, Immunosuppressive Therapy, Central nervous system, Children.Abstract
Objectives: The objectives of the study were to determine the complications of anticoagulants in acute phase, and of low dose Aspirin with and without Azathioprine in remission and maintenance phases in patients with arterial ischemic strokes (AIS).
Study Type: observational and analytic.
Place: The department of the Neurology of the Children’s Hospital Lahore-Pakistan.
Setting and Duration: The study was conducted at the department of the Neurology of the Children's Hospital from 1st Jan 2009 to 31st December 2010.
Methods: Over the period of 2 years, 68 patients with acute ischemic strokes were admitted, who presented within 14 days of onset of the symptoms. Patients with AIS were treated with anticoagulants at least for 04 weeks and this was followed by long term use of Aspirin. Patients ais due to progressive arteriopathy were treated with Azathioprine. Patient were followed in Hospital based cohort study at single center and were systemically assessed for clinical presentation, classification of choldhood primary ischaemic stroke (cPIS), adverse effects of anticoagulants, aspirin and azathioprine.
Statistical Analysis: Data were analyzed using the Statistical Package for the Social Sciences (SPSS) version 12.0 (Chicago, IL). Frequencies were calculated for categorical data including gender, final outcome and complications of anticoagulation therapy.
Result: 68 children with cPIS (boys 62%, girls 38%) with mean age of 8.5 years (median age 7.4 + 3.5 years), were enrolled in this study.The mean time-interval between the symptoms onset and the patients’ admission to the hospital was 5.6 days (range 1 to 14 days). Motor deficit (70%); headache (64%) and fever (20%) were the commonest symptoms, whereas, hemiparesis (60%); seizure 55 % (focal 35%, generalized 20%); and decreased conscious level (30%), were the commonest neurological findings. Neuroradiological findings of head revealed; ischemic strokes 50 (73.5%); hemorrhagic strokes 10 (14.7%) and ischaemic- haemorrhagic lesions 8(11.8%). Conventional angiography and/or MRA revealed that at the time of admission 51 (51/68, 75%) of the cohort had non-progressive (obliterative) and 17 (17/68,25%) had evidence of progressive arteriopathy. No secondary hemorrhagic was documented among infarcts strokes, who were treated with heparin and anticoagulants. Hospital outcome was as; survivors 56 (81.5%) and deaths 12 (18.5%). 40patints discharged on long term oral aspirin, and 14 children of these were commenced also on Azathioprine and are on follow-up. The Neurological findings among 56 survivors were; normal 20%; minor disabilities 25%; moderate disabilities 20% and severe disabilities 35%.
Conclusions and Recommendations: The spectrum of cPIS in children includes both progressive and nonprogressive forms. Characteristic features at diagnosis can be used to predict later progression, and to guide selection of patients for immunosuppressive therapy. Further studies are required to substantiate our findings.
References
Lie JT. Primary (granulomatous) angiitis of the central nervous system: a clinicopathological analysis of 15 new cases and a review of the litratine. Hum Pathol 1992; 23: 164-71. http://dx.doi.org/10.1016/0046-8177(92)90238-X
Benseler SM, Silverman E, Aviv RI, et al. Primary central nervous system vasculitis in children. Arthritis Rheum 2006; 54: 1291-97. http://dx.doi.org/10.1002/art.21766
Bensiler S, Schneider R. Central nervous system vasculitis in children. Curr Opin Rheumatol 2003; 16: 43-50. http://dx.doi.org/10.1097/00002281-200401000-00009
Haff Ali AR. Primary angiitis of the central nervous system differential diagnosis and treatment. Clin Rhematol 2010; 24: 413-28.
Hutchison C, Elibers I, Halliday W, Brasen H, Langtion S, Arnistrong D, et al. Treatment of primary CNS vasculitis in children: an open label cohort study. Lancet Neurol 2010; 9: 1078-84. http://dx.doi.org/10.1016/S1474-4422(10)70243-X
Calabrese LH, Furlan AJ, Gragg LA, Ropos TJ. Primary angiitis of the central nervous system: diagnostic criteria and clinical approach. Cleve Clin J Med 1992; 59: 293-306. http://dx.doi.org/10.3949/ccjm.59.3.293
Despina E, Tim C, Dawn S, Nigel J, Paul AB, Vijey G. Investigation of childhood central nervous system vasculitis: magnetic resonance angiography versus catheter cerebral angiography. Develop Med Child Neurol 2010; 52: 863-67. http://dx.doi.org/10.1111/j.1469-8749.2009.03591.x
Chung B, Wong V. Pediatric stroke among Hong Kong Chinese subjects. Pediatrics 2004; 114: 206-12. http://dx.doi.org/10.1542/peds.114.2.e206
Salih MA, bdel-Gader AG, Al-Jarallah AA, Kentab AY, Alorainy IA, Hassan HH, et al. Stroke in Saudi children: Epidemiology, clinical features and risk factors. Saudi Med J 2006; 27: 12-20.
Sträter R, Becker S, von Eckardstein A, et al. Prospective assessment of risk factors for recurrent stroke during childhood—a 5-year follow-up study. Lancet 2002; 360: 1540. http://dx.doi.org/10.1016/S0140-6736(02)11520-0
Soman T, Rafay FM, Hune S, et al. The Risks and Safety of Clopidogrel in Pediatric Arterial Ischemic Stroke. Stroke 2006; 37: 1120-22. http://dx.doi.org/10.1161/01.STR.0000209620.44017.97
DeVeber G, Monagle P, Chan A, MacGregor D, Curtis R, Lee S, et al. Prothrombotic disorders in infants and children with cerebral thromboembolism. Arch Neurol 1998; 55: 1539-43. http://dx.doi.org/10.1001/archneur.55.12.1539
Barnes C, Newall F, Furmedge J, MMackay M, Monagle P. Arterial ischaemic stroke in children. J Paediatr Child Health 2004; 40: 384-87. http://dx.doi.org/10.1111/j.1440-1754.2004.00407.x
Adams JR, Donald J, Granger SB, et al. Stroke and conversion to high risk in children screened with transcranial Doppler ultrasound. STOP Study 2004; 103: 3689-94.
Juin-Chang L, Kuang-Lin L, Huer-Shyong W, et al. Seizures in childhood ischaemic stroke in Taiwan. Brain Develop 2009; 31: 294-99. http://dx.doi.org/10.1016/j.braindev.2008.05.006
Siddiqui TS, Rehman A, Ahmed B. Etiology of strokes and hemiplegia in children presenting at Ayub Teaching Hospital, Abbottabad. J Ayub Med Coll Abbottabad 2006; 18: 60-63.
Shi KL, Wang JJ, Li JW, Jiang LQ, Mix E, Fang F, et al. Arterial ischemic stroke: experience in Chinese children. Pediatr Neurol 2008; 38: 186-90. http://dx.doi.org/10.1016/j.pediatrneurol.2007.11.002
Lanthier S. Stroke in children: The coexistence of multiple risk factors predicts poor outcome. Neurology 2000; 54: 271- 75. http://dx.doi.org/10.1212/WNL.54.2.371
Nagaraja D, Verma A, Taly AB, Kumar MV, Jayakumar PN. Cerebrovascular disease in children. Acta Neurol Scand 1994; 90: 251-55. http://dx.doi.org/10.1111/j.1600-0404.1994.tb02716.x
Braun JPK, Rafav FM, Uiterwaal CSP, Anne-Marie P, DeVeber G. Mode of Onset Predicts Etiological Diagnosis of Arterial Ischemic Stroke in Children. Stroke 2007; 38: 298- 302. http://dx.doi.org/10.1161/01.STR.0000254484.10680.c6
Sonia M, Aneja S, Tripathi PR, Narayan S. Etiolological Profile of Stroke and its Relation with pro-thrombotic states. Indian J Paediatr 2008; 75: 579-84. http://dx.doi.org/10.1007/s12098-008-0112-8
Cnossen MH. Paediatric arterial ischaemic stroke: functional outcome and risk factors. Dev Med Child Neurol 2010; 52: 394-9. http://dx.doi.org/10.1111/j.1469-8749.2009.03580.x
Stephen D, Weigand MS, Miller DV, Giannini C, Meschia JF, Huston J III, Hunder GG. Neurocrit Care 2010 12: 132-43.
Bourdette DN, Bhardwaj A. Immunomodulatory Therapies in Neurologic Critical Care. Neurocrit Care 2010; 12: 132-43. http://dx.doi.org/10.1007/s12028-009-9274-0
Hankey GJ. Secondary prevention of recurrent stroke. Stroke 2005; 36: 218-21. http://dx.doi.org/10.1161/01.STR.0000153048.87248.3b